home · filing · 0000950170-23-011424
8-K filed March 31, 2023, 7:59 PM ET
ticker GRCE
CIK 0001444192
leadership
confidence high
sentiment neutral
materiality 0.10
Director John Canan resigns from Acasti Pharma board, no dispute
Grace Therapeutics, Inc.
Jean-Marie (John) Canan resigned from the board effective March 30, 2023.
Canan was a member of the audit committee and governance and human resources committee.
Resignation was not due to any dispute or disagreement with the Company or board.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2023-03-30
Filed March 31, 2023, 7:59 PM ET
On March 30, 2023, Mr. Jean-Marie (John) Canan resigned from the board of directors of Acasti Pharma Inc. (the "Company"), effective immediately.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jean-Marie (John) Canan resigned as director at Grace Therapeutics, Inc..
Action resigned
Role director
Exact text from the filing
On March 30, 2023, Mr. Jean-Marie (John) Canan resigned from the board of directors of Acasti Pharma Inc. (the "Company"), effective immediately.
View on SEC.gov
Source: SEC EDGAR
accession 0000950170-23-011424
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.